Document is current
Any future updates will be listed below
-
Authors
Bergenfelz, Caroline http://orcid.org/0000-0001-9337-7285
Roxå, Anna
Mehmeti, Meliha
Leandersson, Karin
Larsson, Anna-Maria
-
Funding
Funding for this research was provided by:
Cancerfonden (-)
Vetenskapsrådet (-)
Allmänna Sjukhusets i Malmö Stiftelse för Bekämpande av Cancer (-)
Gunnar Nilssons Cancerstiftelse (-)
Ollie och Elof Ericssons Stiftelse (-)
governmental funding of clinical research within the national health service (-, -)
Gyllenstiernska Krapperups stiftelsen (-)
Svenska Sällskapet för Medicinsk Forskning (-)
- License Information
-
More Information
Article History
Received: 31 May 2019
Accepted: 31 December 2019
First Online: 10 January 2020
Compliance with ethical standards
:
: The authors declare no conflict of interests.
: The present study is a sub-study of the prospective observational CTC-MBC study (ClinicalTrials.gov NCT01322893) including 156 women with newly diagnosed MBC (Ethical permit number: Dnr 2010/135, Dnr 2010/477 and Dnr 2011/748 for the CTC-MBC study as well as the present sub-study). Ethical permit number for anonymous healthy blood donors: Dnr 2014/669. All work has been approved by the Regional Ethics Committee in Lund and been performed in accordance with the Declaration of Helsinki.
: All included patients and healthy blood donors signed a written informed consent, for research use of specimens and publication of data, at the time of inclusion in the clinical trial or when donating blood for clinical use, respectively.
